Inovio Pharmaceuticals, Inc. (INO) stock
INONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.63+0.23 (+16.43%)
Close on Nov 17, 2026Market cap $168.54MP/E –Yield –
Inovio Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Inovio Pharmaceuticals's operating margin for the twelve months ending Dec 31, 2025 was -132871.3%. For fiscal 2025 it was -132871.3%, against -51616.9% the year before. The highest annual figure on record is -84.5% in fiscal 2015.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -132871.3% | −81254.4 |
| FY2024 | Dec 31, 2024 | -51616.9% | −34316.6 |
| FY2023 | Dec 31, 2023 | -17300.3% | −14692.9 |
| FY2022 | Dec 31, 2022 | -2607.4% | +14365.0 |
| FY2021 | Dec 31, 2021 | -16972.3% | −15298.1 |
| FY2020 | Dec 31, 2020 | -1674.2% | +1027.9 |
| FY2019 | Dec 31, 2019 | -2702.1% | −2393.4 |
| FY2018 | Dec 31, 2018 | -308.7% | −110.6 |
| FY2017 | Dec 31, 2017 | -198.1% | +17.4 |
| FY2016 | Dec 31, 2016 | -215.5% | −131.0 |
| FY2015 | Dec 31, 2015 | -84.5% | +293.2 |
| FY2014 | Dec 31, 2014 | -377.7% | −232.6 |
| FY2013 | Dec 31, 2013 | -145.1% | +425.3 |
| FY2012 | Dec 31, 2012 | -570.4% | −349.5 |
| FY2011 | Dec 31, 2011 | -220.9% | +91.9 |
| FY2010 | Dec 31, 2010 | -312.8% | −159.7 |
| FY2009 | Dec 31, 2009 | -153.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | -38337.0% | −29184.3 |
| Q4 FY2024 | Dec 31, 2024 | -17410.8% | −1018.8 |
| Q2 FY2024 | Jun 30, 2024 | -32945.9% | +5292.4 |
| Q4 FY2023 | Dec 31, 2023 | -26686.3% | +18190.5 |
| Q3 FY2023 | Sep 30, 2023 | -9152.6% | −8762.0 |
| Q2 FY2023 | Jun 30, 2023 | -16392.0% | −3115.8 |
| Q1 FY2023 | Mar 31, 2023 | -38238.2% | −2204.9 |
| Q4 FY2022 | Dec 31, 2022 | -44876.8% | −32303.1 |
| Q3 FY2022 | Sep 30, 2022 | -390.6% | +20162.5 |
| Q2 FY2022 | Jun 30, 2022 | -13276.1% | +17220.4 |
| Q1 FY2022 | Mar 31, 2022 | -36033.3% | −21872.3 |
| Q4 FY2021 | Dec 31, 2021 | -12573.8% | −12048.0 |
| Q3 FY2021 | Sep 30, 2021 | -20553.2% | −5170.9 |
| Q2 FY2021 | Jun 30, 2021 | -30496.6% | −18078.0 |
| Q1 FY2021 | Mar 31, 2021 | -14161.1% | −12260.0 |
| Q4 FY2020 | Dec 31, 2020 | -525.7% | +10358.8 |
| Q3 FY2020 | Sep 30, 2020 | -15382.2% | −12619.2 |
| Q2 FY2020 | Jun 30, 2020 | -12418.6% | +8367.2 |
| Q1 FY2020 | Mar 31, 2020 | -1901.1% | −892.7 |
| Q4 FY2019 | Dec 31, 2019 | -10884.6% | −9705.8 |
| Q3 FY2019 | Sep 30, 2019 | -2763.0% | −1431.5 |
| Q2 FY2019 | Jun 30, 2019 | -20785.8% | −20764.5 |
| Q1 FY2019 | Mar 31, 2019 | -1008.3% | +1132.4 |
| Q4 FY2018 | Dec 31, 2018 | -1178.7% | −918.3 |
| Q3 FY2018 | Sep 30, 2018 | -1331.6% | −227.9 |
| Q2 FY2018 | Jun 30, 2018 | -21.3% | +25.9 |
| Q1 FY2018 | Mar 31, 2018 | -2140.8% | −1929.4 |
| Q4 FY2017 | Dec 31, 2017 | -260.5% | +2.2 |
| Q3 FY2017 | Sep 30, 2017 | -1103.6% | −942.6 |
| Q2 FY2017 | Jun 30, 2017 | -47.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -211.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -262.7% | – |
| Q3 FY2016 | Sep 30, 2016 | -161.0% | – |
See a number that looks wrong?